{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:11:40Z","timestamp":1793434300380,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":113,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Informatics in Medicine Unlocked"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.imu.2023.101256","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T14:14:49Z","timestamp":1682432089000},"page":"101256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Mutations of SARS-CoV-2 and their impact on disease diagnosis and severity"],"prefix":"10.1016","volume":"39","author":[{"given":"Laiali","family":"Alquraan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karem H.","family":"Alzoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzie Y.","family":"Rababa'h","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imu.2023.101256_bib1","series-title":"The SARS-CoV-2 outbreak from a one health perspective","author":"Hemida","year":"2020"},{"issue":"7798","key":"10.1016\/j.imu.2023.101256_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.imu.2023.101256_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/v12060598","article-title":"Reporter replicons for antiviral drug discovery against positive single-stranded RNA viruses","volume":"12","author":"Fernandes","year":"2020","journal-title":"Viruses"},{"issue":"37","key":"10.1016\/j.imu.2023.101256_bib4","doi-asserted-by":"crossref","first-page":"E3900","DOI":"10.1073\/pnas.1323705111","article-title":"One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities","volume":"111","author":"Subissi","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.imu.2023.101256_bib5","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1016\/j.ygeno.2020.04.016","article-title":"Genotyping coronavirus SARS-CoV-2: methods and implications","volume":"112","author":"Yin","year":"2020","journal-title":"Genomics"},{"issue":"5","key":"10.1016\/j.imu.2023.101256_bib76","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3390\/pathogens9050331","article-title":"The human coronavirus disease COVID-19: its origin, characteristics, and insights into potential drugs and its mechanisms","volume":"9","author":"Alanagreh","year":"2020","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.imu.2023.101256_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host & Microbe"},{"issue":"9","key":"10.1016\/j.imu.2023.101256_bib91","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s10096-020-03899-4","article-title":"The genetic sequence, origin, and diagnosis of SARS-CoV-2","volume":"39","author":"Wang","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.imu.2023.101256_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.micinf.2020.01.004","article-title":"Pathogenicity and transmissibility of 2019-nCoV\u2014a quick overview and comparison with other emerging viruses","volume":"22","author":"Chen","year":"2020","journal-title":"Microb Infect"},{"key":"10.1016\/j.imu.2023.101256_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105969","article-title":"Predicting COVID-19 disease severity from SARS-CoV-2 spike protein sequence by mixed effects machine learning","volume":"149","author":"Sokhansanj","year":"2022","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.imu.2023.101256_bib8","article-title":"RdRp mutations are associated with SARS-CoV-2 genome evolution","volume":"8","author":"Eskier","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.imu.2023.101256_bib9","series-title":"An Overview of Mutations Occurring within the Coronavirus-2 Genome: Mutations Data Reporting on SARS-CoV-2","author":"Chatterjee","year":"2020"},{"key":"10.1016\/j.imu.2023.101256_bib10","first-page":"1","article-title":"SARS-CoV-2 genomic variations associated with mortality rate of COVID-19","author":"Toyoshima","year":"2020","journal-title":"J Hum Genet"},{"key":"10.1016\/j.imu.2023.101256_bib92","article-title":"The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity","author":"Zhang","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.imu.2023.101256_bib79","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.9703","article-title":"Mutation density changes in SARS-CoV-2 are related to the pandemic stage but to a lesser extent in the dominant strain with mutations in spike and RdRp","volume":"8","author":"Eskier","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.imu.2023.101256_bib11","series-title":"Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis","author":"Sardar","year":"2020"},{"issue":"5","key":"10.1016\/j.imu.2023.101256_bib12","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2020.07.012","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.imu.2023.101256_bib81","series-title":"The D614G mutation of SARS-CoV-2 spike protein enhances viral infectivity","author":"Hu","year":"2020"},{"issue":"4","key":"10.1016\/j.imu.2023.101256_bib13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.imu.2023.101256_bib14","series-title":"Emergence of RBD mutations in circulating SARS-CoV-2 strains enhancing the structural stability and human ACE2 receptor affinity of the spike protein 2","author":"Ou","year":"2020"},{"key":"10.1016\/j.imu.2023.101256_bib15","series-title":"Patient-derived mutations impact pathogenicity of SARS-CoV-2.MedRxiv","author":"Yao","year":"2020"},{"key":"10.1016\/j.imu.2023.101256_bib16","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.2147\/IDR.S319439","article-title":"First report of SARS-CoV-2 lineage B. 1.1. 7 (alpha variant) in Ecuador, january 2021","volume":"14","author":"Carrazco-Montalvo","year":"2021","journal-title":"Infect Drug Resist"},{"issue":"3","key":"10.1016\/j.imu.2023.101256_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/vaccines9030243","article-title":"Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2\/COVID-19","volume":"9","author":"G\u00f3mez","year":"2021","journal-title":"Vaccines"},{"issue":"18","key":"10.1016\/j.imu.2023.101256_bib18","doi-asserted-by":"crossref","first-page":"10367","DOI":"10.1002\/ange.202100316","article-title":"A SARS-CoV-2 spike binding DNA aptamer that inhibits pseudovirus infection in vitro by an RBD independent mechanism","volume":"133","author":"Schmitz","year":"2021","journal-title":"Angew Chem Weinheim Bergstr Ger"},{"key":"10.1016\/j.imu.2023.101256_bib19","doi-asserted-by":"crossref","first-page":"m4944","DOI":"10.1136\/bmj.m4944","article-title":"Covid-19: what have we learnt about the new variant in the UK? 2020","volume":"371","author":"Mahase","year":"2020","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.imu.2023.101256_bib20","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jama.2021.1612","article-title":"Emergence of a novel SARS-CoV-2 variant in Southern California","volume":"325","author":"Zhang","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.imu.2023.101256_bib21","series-title":"Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil.medRxiv","author":"Faria","year":"2021"},{"issue":"11","key":"10.1016\/j.imu.2023.101256_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3349\/ymj.2021.62.11.961","article-title":"SARS-CoV-2 variants of concern","volume":"62","author":"Choi","year":"2021","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.imu.2023.101256_bib23","series-title":"The India mutations and B. 1.617","author":"Perez","year":"2021"},{"key":"10.1016\/j.imu.2023.101256_bib85","series-title":"SARS-CoV-2 B. 1.617. 2 Delta variant emergence, replication and sensitivity to neutralising antibodies. bioRxiv","author":"Mlcochova","year":"2021"},{"issue":"7883","key":"10.1016\/j.imu.2023.101256_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"issue":"83\u201385","key":"10.1016\/j.imu.2023.101256_bib25","article-title":"A comprehensive review on Covid-19 Delta variant","volume":"5","author":"Alexandar","year":"2021","journal-title":"Int J Pharmaceut Chem Res"},{"key":"10.1016\/j.imu.2023.101256_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cegh.2022.100974","article-title":"The outbreak of Delta Plus variant: the notorious and novel strain of SARS-CoV-2","volume":"14","author":"Richi","year":"2022","journal-title":"Clinical Epidemiology and Global Health"},{"issue":"4","key":"10.1016\/j.imu.2023.101256_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01140-21","article-title":"Evolution, mode of transmission, and mutational landscape of newly emerging SARS-CoV-2 variants","volume":"12","author":"Chakraborty","year":"2021","journal-title":"mBio"},{"issue":"10317","key":"10.1016\/j.imu.2023.101256_bib28","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.imu.2023.101256_bib29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/mco2.110","article-title":"SARS\u2010CoV\u20102 Omicron variant: characteristics and prevention","volume":"2","author":"He","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.imu.2023.101256_bib30","series-title":"Omicron variant (B. 1.1. 529) and its sublineages: what do we know so far amid the emergence of recombinant variants of SARS-CoV-2?","author":"Dhawan","year":"2022"},{"issue":"1","key":"10.1016\/j.imu.2023.101256_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28138","article-title":"The outbreak of SARS\u2010CoV\u20102 Omicron lineages, immune escape and vaccine effectivity","volume":"95","author":"Zhou","year":"2023","journal-title":"J Med Virol"},{"issue":"15","key":"10.1016\/j.imu.2023.101256_bib31","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMc2201933","article-title":"Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA. 2","volume":"386","author":"Takashita","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imu.2023.101256_bib32","first-page":"376","article-title":"Covid-19: what do we know about omicron sublineages?","author":"Mahase","year":"2022","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.imu.2023.101256_bib89","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/10408363.2021.1979462","article-title":"The COVID-19 pandemic: viral variants and vaccine efficacy","volume":"59","author":"Ciotti","year":"2022","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.imu.2023.101256_bib33","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3389\/fmicb.2020.01800","article-title":"Geographic and genomic distribution of SARS-CoV-2 mutations","author":"Mercatelli","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.imu.2023.101256_bib34","article-title":"Full vaccination against COVID-19 suppresses SARS-CoV-2 delta variant and spike gene mutation frequencies and generates purifying selection pressure","author":"Yeh","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.imu.2023.101256_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104831","article-title":"Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus","volume":"154","author":"Bakhshandeh","year":"2021","journal-title":"Microb Pathog"},{"key":"10.1016\/j.imu.2023.101256_bib36","first-page":"1","article-title":"Antibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.imu.2023.101256_bib93","series-title":"Genomic variations of SARS-CoV-2 suggest multiple outbreak sources of transmission","author":"Zhang","year":"2020"},{"key":"10.1016\/j.imu.2023.101256_bib82","article-title":"Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity","volume":"2020-04","author":"Jia","year":"2021","journal-title":"BioRxiv"},{"key":"10.1016\/j.imu.2023.101256_bib37","series-title":"RNA-dependent RNA polymerase and spike protein mutant variants of SARS-CoV-2 predominate in severely affected COVID-19 patients","author":"Biswas","year":"2020"},{"issue":"4","key":"10.1016\/j.imu.2023.101256_bib38","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jinf.2020.12.024","article-title":"Emergence of a new SARS-CoV-2 variant in the UK","volume":"82","author":"Tang","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.imu.2023.101256_bib39","first-page":"m4857","volume":"371","author":"Wise","year":"2020"},{"issue":"17","key":"10.1016\/j.imu.2023.101256_bib40","doi-asserted-by":"crossref","first-page":"9131","DOI":"10.3390\/ijms22179131","article-title":"Possible link between higher transmissibility of alpha, kappa and delta variants of SARS-CoV-2 and increased structural stability of its spike protein and hACE2 affinity","volume":"22","author":"Kumar","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.imu.2023.101256_bib86","series-title":"Hidden genomic diversity of SARS-CoV-2: implications for qRT-PCR diagnostics and transmission","author":"Sapoval","year":"2021"},{"issue":"7","key":"10.1016\/j.imu.2023.101256_bib41","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.3390\/microorganisms9071542","article-title":"SARS-CoV-2 spike mutations, L452R, T478K, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India","volume":"9","author":"Cherian","year":"2021","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.imu.2023.101256_bib42","first-page":"2","article-title":"SARS-CoV-2 B. 1.617. 2 (Delta), B. 1.617. 2.1 (Delta Plus) Variant and vaccine strategies. Research & Reviews: a journal of medical science and technology","volume":"1","author":"Kamble","year":"2021","journal-title":"SARS-CoV-2 B"},{"key":"10.1016\/j.imu.2023.101256_bib43","series-title":"Covid-19: omicron may be more transmissible than other variants and partly resistant to existing vaccines","author":"Torjesen","year":"2021"},{"issue":"1","key":"10.1016\/j.imu.2023.101256_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12998\/wjcc.v10.i1.1","article-title":"Omicron variant (B. 1.1. 529) of SARS-CoV-2: mutation, infectivity, transmission, and vaccine resistance","volume":"10","author":"Ren","year":"2022","journal-title":"World J.Clin.Cases"},{"issue":"5","key":"10.1016\/j.imu.2023.101256_bib45","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/jmv.27588","article-title":"Omicron variant of SARS\u2010CoV\u20102: genomics, transmissibility, and responses to current COVID\u201019 vaccines","volume":"94","author":"Araf","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.imu.2023.101256_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.127099","article-title":"Mutational dynamics across VOCs in International travellers and Community transmission underscores importance of Spike-ACE2 interaction","volume":"262","author":"Mehta","year":"2022","journal-title":"Microbiol Res"},{"key":"10.1016\/j.imu.2023.101256_bib47","series-title":"Transmission of SARS-CoV-2 omicron VOC subvariants BA. 1 and BA. 2: evidence from Danish households","author":"Lyngse","year":"2022"},{"key":"10.1016\/j.imu.2023.101256_bib48","doi-asserted-by":"crossref","first-page":"1090717","DOI":"10.3389\/fphar.2023.1090717","article-title":"Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development","volume":"14","author":"Islam","year":"2023","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.imu.2023.101256_bib49","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.3390\/jcm10122635","article-title":"SARS-CoV-2 infectivity and severity of COVID-19 according to SARS-CoV-2 variants: current evidence","volume":"10","author":"Dao","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.imu.2023.101256_bib50","doi-asserted-by":"crossref","first-page":"n579","DOI":"10.1136\/bmj.n579","article-title":"Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012\/1: matched cohort study","volume":"372","author":"Challen","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.imu.2023.101256_bib51","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.11.2100256","article-title":"Case fatality risk of the SARS-CoV-2 variant of concern B. 1.1. 7 in England, 16 November to 5 February","volume":"26","author":"Grint","year":"2021","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.imu.2023.101256_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","article-title":"Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B. 1.617. 2) compared with alpha (B. 1.1. 7) variants of concern: a cohort study","volume":"22","author":"Twohig","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.imu.2023.101256_bib53","series-title":"Early estimates of SARS-CoV-2 Omicron variant severity based on a matched cohort study","author":"Ulloa","year":"2021"},{"key":"10.1016\/j.imu.2023.101256_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070695","article-title":"Risk of covid-19 related deaths for SARS-CoV-2 omicron (B. 1.1. 529) compared with delta (B. 1.617. 2): retrospective cohort study","volume":"378","author":"Ward","year":"2022","journal-title":"BMJ"},{"issue":"10332","key":"10.1016\/j.imu.2023.101256_bib55","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.imu.2023.101256_bib56","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3390\/vaccines10060919","article-title":"Biological properties of SARS-CoV-2 variants: epidemiological impact and clinical consequences","volume":"10","author":"Hoteit","year":"2022","journal-title":"Vaccines"},{"issue":"12","key":"10.1016\/j.imu.2023.101256_bib77","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00109-020-01992-x","article-title":"Diagnosing the novel SARS-CoV-2 by quantitative RT-PCR: variations and opportunities","volume":"98","author":"Barreto","year":"2020","journal-title":"J Mol Med"},{"key":"10.1016\/j.imu.2023.101256_bib57","first-page":"1","article-title":"SARS-CoV-2 pandemic: a review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations","author":"Jayamohan","year":"2020","journal-title":"Anal Bioanal Chem"},{"issue":"22","key":"10.1016\/j.imu.2023.101256_bib58","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.2020.8259","article-title":"Interpreting diagnostic tests for SARS-CoV-2","volume":"323","author":"Sethuraman","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.imu.2023.101256_bib59","doi-asserted-by":"crossref","first-page":"e00557","DOI":"10.1128\/JCM.00557-20","article-title":"Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit","volume":"58","author":"Nalla","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1016\/j.imu.2023.101256_bib60","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/pathogens9070580","article-title":"Genetic diversity among SARS-CoV-2 strains in South America may impact performance of molecular detection","volume":"9","author":"Ram\u00edrez","year":"2020","journal-title":"Pathogens"},{"issue":"12","key":"10.1016\/j.imu.2023.101256_bib83","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s42399-021-01059-z","article-title":"False-negative rt-pcr findings and double mutant variant as factors of an overwhelming second wave of covid-19 in India: an emerging global health disaster","volume":"3","author":"Jindal","year":"2021","journal-title":"SN Compr Clin Med"},{"issue":"5","key":"10.1016\/j.imu.2023.101256_bib61","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/jmv.26823","article-title":"Will the emergent SARS\u2010CoV2 B. 1.1. 7 lineage affect molecular diagnosis of COVID\u201019?","volume":"93","author":"Ram\u00edrez","year":"2021","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.imu.2023.101256_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01598-20","article-title":"A recurrent mutation at position 26340 of SARS-CoV-2 is associated with failure of the E gene quantitative reverse transcription-PCR utilized in a commercial dual-target diagnostic assay","volume":"58","author":"Artesi","year":"2020","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.imu.2023.101256_bib63","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Euro Surveill"},{"issue":"10","key":"10.1016\/j.imu.2023.101256_bib64","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41564-020-0761-6","article-title":"Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT\u2013qPCR primer\u2013probe sets","volume":"5","author":"Vogels","year":"2020","journal-title":"Nat Microbiol"},{"issue":"12","key":"10.1016\/j.imu.2023.101256_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001030","article-title":"A sensitive and affordable multiplex RT-qPCR assay for SARS-CoV-2 detection","volume":"18","author":"Reijns","year":"2020","journal-title":"PLoS Biol"},{"issue":"2","key":"10.1016\/j.imu.2023.101256_bib66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/ams.ams_2_22","article-title":"S-gene Dropout and False-negative reverse transcriptase-polymerase chain reaction tests","volume":"11","author":"Balaji","year":"2021","journal-title":"Ann Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.imu.2023.101256_bib67","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jmii.2020.04.015","article-title":"ACE2 receptor polymorphism: susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome","volume":"53","author":"Devaux","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"issue":"9","key":"10.1016\/j.imu.2023.101256_bib68","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"10.1016\/j.imu.2023.101256_bib69","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jama.2021.1114","article-title":"SARS-CoV-2 vaccines and the growing threat of viral variants","volume":"325","author":"Moore","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.imu.2023.101256_bib70","first-page":"1","article-title":"mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants","author":"Wu","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.imu.2023.101256_bib71","first-page":"1","article-title":"SARS-CoV-2 501Y. V2 escapes neutralization by South African COVID-19 donor plasma","author":"Wibmer","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.imu.2023.101256_bib72","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.imu.2023.101256_bib73","series-title":"Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies","author":"Wilhelm","year":"2021"},{"issue":"10","key":"10.1016\/j.imu.2023.101256_bib74","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/vaccines9101195","article-title":"Emerging SARS-CoV-2 variants: a review of its mutations, its implications and vaccine efficacy","volume":"9","author":"Ramesh","year":"2021","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.imu.2023.101256_bib78","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1016\/S2666-5247(21)00267-6","article-title":"Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis","volume":"3","author":"Cromer","year":"2022","journal-title":"The Lancet Microbe"},{"issue":"8","key":"10.1016\/j.imu.2023.101256_bib75","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S1473-3099(22)00409-1","article-title":"Duration of effectiveness of vaccination against COVID-19 caused by the omicron variant","volume":"22","author":"Higdon","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.imu.2023.101256_bib80","series-title":"Neutralization of SARS-CoV-2 Omicron sub-lineages BA. 1, BA. 1.1, and BA. 2.Cell host & microbe","author":"Evans","year":"2022"}],"container-title":["Informatics in Medicine Unlocked"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352914823000989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352914823000989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:27:13Z","timestamp":1762493233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352914823000989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":91,"alternative-id":["S2352914823000989"],"URL":"https:\/\/doi.org\/10.1016\/j.imu.2023.101256","relation":{},"ISSN":["2352-9148"],"issn-type":[{"value":"2352-9148","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutations of SARS-CoV-2 and their impact on disease diagnosis and severity","name":"articletitle","label":"Article Title"},{"value":"Informatics in Medicine Unlocked","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imu.2023.101256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101256"}}